**Abstract**

**Objective:** In Japan, there are many regulation of national health insurance to the psychiatric acute inpatient unit. For example over 60% patients must be legal forced hospitalization on admission and have to discharge within 3 months. Therefore differences between medication in the psychiatric acute inpatient unit with guidelines crarify actual clinical medication.

**Method:** We researched medication of bipolar disorder in the psychiatric acute inpatient units in Karasuyama Hospital. All patients admitted between 2010 and 2013 were retrospectively followed through medical records. We investigated the use of antipsychotics, moodstabilizers, antidepressants and benzodiazepines to bipolar disorder on admission and discharge.

**Results:** 1899 patients admitted to psychiatric acute inpatient units of Karasuama Hospital and 221 patients were bipolar disorder diagnosed by ICD-10. 78 patients were manic phase and 112 patients were depressive phase on admission. Mood stabilizer and antipsychotics had been respectively prescribed 59.7% and 76.5% on admission, and 75.1% and 83.3% on discharge. Over 70% of bipolar patients discharged within 3 months.

**Conclusion:** It was more useful to use antipsychotics than mood stabilizer when the start of treatment in the actual clinical medication to bipolar disorder. While there are differences from guidelines the treatment of bipolar disorder had been largely successful on the rules of national health insurance in the psychiatric acute inpatient unit of Karasuyama Hospital. It is necessary to clarify the difference between the evidences and actual clinical medication.
